Trial intelligence / Profile preview

Youxinding capsule in depression (phase 2)

CTR20211634Phase 2Completed

Sponsor
Shanghai Innovative Research Center of Traditional Chinese Medicine
Start
Jul 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of youxinding in major depressive disorder (MDD), sponsored by Shanghai Innovative Research Center of Traditional Chinese Medicine. Started Jul 2021; status: completed.

02

Drugs

youxinding
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on CTR20211634.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20211634.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call